Outcomes-based Pharmaceutical Pricing: Meeting Stakeholder Needs- Aarkstore Enterprise
The pricing landscape has changed dramatically over the past decade
. In the 1990s and even a few years ago, pricing was almost an afterthought pricing plans were formed and carried out during ramp-up to product launch; there was less regulatory scrutiny; the concept of health outcomes analysis was still taking shape, and any pharmacoeconomic data that companies were able to provide was better than none.
Today, however, strategic pricing is more important than ever before. Pharmaceutical and biotechnology companies' pricing teams contend with unrelenting pressures. They must manage increased scrutiny from different sides government agencies, the media and the public over pharmaceutical pricing, while meeting multiple stakeholders' needs: third-party payers, physicians and patients. Adding to the complexity are ever-rising clinical development costs and shrinking pipelines in a constantly changing, global marketplace.
As a result of these challenges, pharmaceutical pricing has become payer-driven and value-based. But life sciences companies are also recognizing the vital importance of strategic pricing. Rather than coming at the tail end of a drug's development, pricing planning is being integrated into drug development. The pricing department, in fact, is now a key driver in lifecycle management.
Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder Needs examines these industry trends. It provides action items to resolve pricing departments' most pressing problems. Above all, it shows how forward-thinking companies maximize profits by addressing customers' preferences and ensuring that they set the right prices for their products. Use the report to:
For more information please contact :
http://www.aarkstore.com/reports/Outcomes-Based-Pharmaceutical-Pricing-Meeting-Stakeholder-Needs-6773.html
http://blogs.aarkstore.com/
From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com
by: Aarkstore
Us Smart Grid Roll-out: Forging Ahead --- Aarkstore Enterprise Iec 61850 Routers And Switches In Smart Grids: Opportunity Analysis To 2015 --- Aarkstore Enterprise Rx To Otc Switches 2009 --- Aarkstore Enterprise Rfid: Scope, Viability And Company Analysis- Aarkstore Enterprise Hybrid Tv And Over The Top Tv Status Report- Aarkstore Enterprise Machine-to-machine (m2m) And Rfid- Aarkstore Enterprise End-to-end M2m, Third Edition- Aarkstore Enterprise Perdue Incorporated ---- Aarkstore Enterprise Montana Upstream Oil & Gas Fiscal Regime: 2010-aarkstore Enterprise Rfid: Scope, Viability And Company Analysis - Aarkstore Enterprise. Machine-to-machine (m2m) And Rfid - Aarkstore Enterprise. The Greenbrier Companies, Inc. - Swot Analysis - Aarkstore Enterprise. Ralcorp Holdings, Inc. - Swot Analysis - Aarkstore Enterprise.
www.yloan.com
guest:
register
|
login
|
search
IP(216.73.216.110) California / Anaheim
Processed in 0.017288 second(s), 7 queries
,
Gzip enabled
, discuz 5.5 through PHP 8.3.9 ,
debug code: 22 , 2071, 353,
Outcomes-based Pharmaceutical Pricing: Meeting Stakeholder Needs- Aarkstore Enterprise Anaheim